John W. V. Umstead, Chief Financial Officer at G1 Therapeutics, Inc. (GTHX), sold 6,547 shares at $3.02 ($20K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
Open-market sale of $20k GTHX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GTHX | SELL | 2024-01-08 | $2K | — | Filing → |